Received Aug 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | H4279 | IM |
Sore arm; Swelling; This non-serious case was reported by a other health professional and described the occurrence of pain in arm in a 44-year-old male patient who received DTPa (Reduced antigen) (dTpa vaccine) (batch number H4279) for prophylaxis. On 21-JUL-2025, the patient received dTpa vaccine (intramuscular) .5 ml. On 21-JUL-2025, less than a day after receiving dTpa vaccine, the patient experienced pain in arm (Verbatim: Sore arm) and swelling (Verbatim: Swelling). The outcome of the pain in arm and swelling were not resolved. It was unknown if the reporter considered the pain in arm and swelling to be related to dTpa vaccine. It was unknown if the company considered the pain in arm and swelling to be related to dTpa vaccine. Additional Information: GSK Receipt Date: 08-AUG-2025 The patient experienced sore arm and swelling. The adverse events were treated. On 08-AUG-2025 the adverse events were ongoing.